Skip to content

Effectiveness of Spinosad 0.9% Lotion for Scabies.

Assessment of Therapeutic Response to Spinosad 0.9% Lotion in Scabies Using Polarized and Ultraviolet Induced Fluorescence Dermoscopy. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108169
Enrollment
60
Registered
2026-04-10
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B86- Scabies

Interventions

Intervention1: Dr Balachandra S Ankad : Spinosad 0.9% topical suspension is applied topically over the entire body (neck down
include scalp in infants/elderly), used as a single application left on for 6 8 hours (overnight) and then washed off
the dose is sufficient to cover all skin, frequency is once with a possible repeat after 7 days if needed, and total duration is usually 1 2 weeks. Control Intervention1: NA: NA

Sponsors

Snmc-Institutional Ethics Committee on Human Subjects Research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with clinically confirmed scabies patients willing to participate in study

Exclusion criteria

Exclusion criteria: Patients with scabies complicated by secondary bacterial infection children below six months of age

Design outcomes

Primary

MeasureTime frame
Dermoscopy-confirmed absence of scabies mites following treatment with Spinosad 0.9% lotionTimepoint: Outcome assessment will be performed at baseline, 4 weeks (primary endpoint), and 8 weeks (follow-up) using clinical examination and dermoscopy to confirm mite clearance and sustained treatment response.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Balachandra Suryakant Ankad

S. Nijalingappa medical college and HSK hospital and research centre,Bagalkot Karnataka 587102

deepanshucool27@gmail.com7988583800

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026